Trials / Withdrawn
WithdrawnNCT06195280
SUPerficial ENDometriosis In Magnetic Resonance Imaging
Prospective, Multicenter Study Evaluating the Diagnostic Performance of the 3DT1 Sequence in Magnetic Resonance Imaging for Superficial Endometriosis
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the correlation between the diagnosis of Superficial endometriosis by the 3DT1 sequence on Magnetic resonance imaging and the histology obtained by laparoscopy.
Detailed description
This is a prospective, multicenter, non-randomized study evaluating the diagnostic performance of Magnetic Resonance Imaging in superficial endometriosis. The duration of the patient's participation in the study is a maximum of 15 months depending on the length of the screening period and the time between Magnetic Resonance Imaging and laparoscopy. After selection, the investigator will check the patient's eligibility and offer her the study. If she accepts and signs the informed consent form, the patient will have an exploratory pelvic Magnetic Resonance Imaging lasting approximately 15 to 20 minutes, without systematic injection of contrast product. After Magnetic Resonance Imaging, the patient will benefit from a laparoscopy under general anesthesia lasting an average of one hour.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Magnetic resonance imaging, 3DT1 sequence | The patient will have an exploration pelvic Magnetic Resonance Imaging lasting approximately 15 to 20 minutes, without systematic injection of contrast product. |
| PROCEDURE | Laparoscopy | After Magnetic Resonance Imaging, the patient will benefit from a laparoscopy under general anesthesia lasting an average of one hour. |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2024-01-08
- Last updated
- 2026-01-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06195280. Inclusion in this directory is not an endorsement.